Analysis of early tumor shrinkage and depth of response in patients with advanced biliary tract cancer treated with gemcitabine plus cisplatin or gemcitabine plus S-1: An exploratory analysis of JCOG1113.

Naohiro Okano,Chigusa Morizane,Takuji Okusaka,Ryo Sadachi,Tomoko Kataoka,Makoto Ueno,Masafumi Ikeda,Masato Ozaka,Kazuya Sugimori,Akiko Todaka,Satoshi Shimizu,Nobumasa Mizuno,Tomohisa Yamamoto,Keiji Sano,Kazutoshi Tobimatsu,Akio Katanuma,Atsushi Miyamoto,Hironori Yamaguchi,Hiroshi Ishii,Junji Furuse

Analysis of early tumor shrinkage and depth of response in patients with advanced biliary tract cancer treated with gemcitabine plus cisplatin or gemcitabine plus S-1: An exploratory analysis of JCOG1113.

2021

301Background: JCOG1113 is a randomized phase III trial to confirm the non-inferiority of gemcitabine (GEM) plus S-1 (GS) compared with GEM plus cisplatin (GC) regarding overall survival (OS) in pa...

Keywords:

Cisplatin
overall survival
biliary tract cancer
Oncology
in patient
exploratory analysis
Internal medicine
Gemcitabine
tumor shrinkage
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations